Condition
Inverted Papilloma
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Bevacizumab800cw
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Unknown2
Clinical Trials (2)
Research Network
Common Treatments
- Bevacizumab800cw1
- Draf Iii Procedure With Lateral Pedicled Nasoseptal Flaps Applied1
- Draf Iii Procedure Without Any Flap Applied1
Active Sponsors
- University Medical Center Groningen1
- Beijing Tongren Hospital1
Top Investigators
Beijing Tongren Hospital
Related Conditions
- Draf Iii Procedure1
- Molecular Fluorescence Imaging1
- Nasoseptal Flap1